Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

The Lovesac Company (NQ: LOVE )

29.09 -0.07 (-0.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about The Lovesac Company

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Evaluating Lovesac: Insights From 4 Financial Analysts
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Lovesac
Via Benzinga
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of The Lovesac Company – LOVE
From The Rosen Law Firm PA
Via GlobeNewswire
Lovesac Reports Q2 Loss Narrower Than Expected, Updates FY2025 Guidance
Lovesac's Q2 loss was narrower than expected, sales missed estimates, and the company updated its FY2025 guidance with a lower outlook. 
Via Benzinga
Topics Earnings
Exposures Financial
Top Wall Street Forecasters Revamp Lovesac Price Expectations Ahead Of Q2 Earnings
Via Benzinga
Deep Dive Into Lovesac Stock: Analyst Perspectives (10 Ratings)
Via Benzinga
Top Wall Street Forecasters Revamp Lovesac Expectations Ahead Of Q1 Earnings
Via Benzinga
Lovesac (LOVE) Q2 2025 Earnings Call Transcript
LOVE earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Here's What Lifted Lovesac Stock Higher Today
The company is navigating a slowing economy but expects strong results to end the year. 
Via The Motley Fool
Topics Economy
Exposures Economy
Signet Jewelers Posts Better-Than-Expected Earnings, Joins NETGEAR, Lovesac And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Q2 2024 U.S. Retail Preview: Strong Apparel Sales
The LSEG U.S. Retail and Restaurant Q2 earnings index, which tracks changes in the growth rate of earnings within the sector, is expected to show a 12.7% growth over last year’s levels. 
Via Talk Markets
Peeling Back The Layers: Exploring Lovesac Through Analyst Insights
Via Benzinga
Expert Ratings For Lovesac
Via Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of The Lovesac Company (LOVE) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Top 3 Small Cap Stocks Emerging as Rotation Winners
Three small cap stocks stand out from the pack as fundamental trends back the thesis behind Wall Street's preference for small caps 
Via MarketBeat
Topics Artificial Intelligence Bonds Economy
Exposures Artificial Intelligence Debt Markets Economy
Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure
Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Tuesday its fiscal third quarter 2024 financial and operating results for the three and... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of The Lovesac Company (LOVE) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Wall Street Favorites: 3 Retail Stocks With Strong Buy Ratings for June 2024
Retail sales are moving at a sluggish pace but several trends suggest a strong revival. Here are three strong buy retail stocks for June. 
Via InvestorPlace
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
Via Benzinga
LOVE Stock Earnings: Lovesac Beats EPS, Beats Revenue for Q1 2025
LOVE stock results show that Lovesac beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025. 
Via InvestorPlace
What's Going On With Home Furnishing Brand Lovesac Shares After Q1 Earnings?
Lovesac (NASDAQ: LOVE) shares rise after reporting Q1 results, with narrower-than-expected loss and strong sales performance. 
Via Benzinga
Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss
Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68%... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Over $1M Bet On Citi Trends? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
7 Budget-Friendly Retail Plays Due for a Tax Refund Spending Boost
These seven budget-friendly retail stocks are showing strong demand, growing earnings, and an e-commerce presence 
Via InvestorPlace
Insiders Buying Lovesac Company And 3 Other Stocks
Via Benzinga
Did You Get the Average $3,011 Tax Refund for Your 2023 Return? 3 No-Brainer Stocks to Buy Now
For those in a financial position to invest in them, this trio of stocks could help build long-term wealth. 
Via The Motley Fool
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. 
Via Benzinga
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
The furniture business is down due to weakness in housing, but long-term indicators are favorable, and the FOMC is on track to cut rates, so a rebound is ahead. 
Via MarketBeat
Lovesac (LOVE) Q4 2024 Earnings Call Transcript
LOVE earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.